Sur Tatil Evleri Gayrimenkul Yatirim Ortakligi Anonim Sirketi (IST:SURGY)
42.28
+2.70 (6.82%)
Feb 28, 2025, 10:00 AM GMT+3
IST:SURGY Statistics
Total Valuation
IST:SURGY has a market cap or net worth of TRY 7.19 billion. The enterprise value is 6.95 billion.
Market Cap | 7.19B |
Enterprise Value | 6.95B |
Important Dates
The next estimated earnings date is Tuesday, April 29, 2025.
Earnings Date | Apr 29, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
IST:SURGY has 167.50 million shares outstanding. The number of shares has increased by 27.16% in one year.
Current Share Class | n/a |
Shares Outstanding | 167.50M |
Shares Change (YoY) | +27.16% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | 0.05% |
Float | 45.00M |
Valuation Ratios
The trailing PE ratio is 38.67.
Price/FFO Ratio | n/a |
Price/AFFO Ratio | n/a |
PE Ratio | 38.67 |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | 1.08 |
P/TBV Ratio | 1.08 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 33.98 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 14.87
Current Ratio | 14.87 |
Quick Ratio | 1.78 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 4.37% and return on invested capital (ROIC) is -0.62%.
Return on Equity (ROE) | 4.37% |
Return on Assets (ROA) | -0.50% |
Return on Invested Capital (ROIC) | -0.62% |
Return on Capital Employed (ROCE) | -0.56% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -18.54% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -18.54% |
50-Day Moving Average | 42.13 |
200-Day Moving Average | 54.00 |
Relative Strength Index (RSI) | 57.69 |
Average Volume (20 Days) | 1,405,322 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -46.07M |
Pretax Income | 204.56M |
Net Income | 204.56M |
EBITDA | -44.67M |
EBIT | -46.07M |
Earnings Per Share (EPS) | 1.11 |
Balance Sheet
The company has 234.02 million in cash and n/a in debt, giving a net cash position of 234.02 million or 1.40 per share.
Cash & Cash Equivalents | 234.02M |
Total Debt | n/a |
Net Cash | 234.02M |
Net Cash Per Share | 1.40 |
Equity (Book Value) | 6.64B |
Book Value Per Share | 39.66 |
Working Capital | 1.83B |
Cash Flow
Operating Cash Flow | -468.93M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
IST:SURGY does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -27.16% |
Shareholder Yield | -27.16% |
Earnings Yield | 2.85% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |